File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1177/02683555231184772
- Scopus: eid_2-s2.0-85162712804
- PMID: 37318342
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Sclerotherapy for congenital vascular malformations with mixing foam of polidocanol and liquid of bleomycin
Title | Sclerotherapy for congenital vascular malformations with mixing foam of polidocanol and liquid of bleomycin |
---|---|
Authors | |
Keywords | bleomycin Congenital vascular malformation polidocanol sclerotherapy venous malformation |
Issue Date | 2023 |
Citation | Phlebology, 2023, v. 38, n. 7, p. 451-457 How to Cite? |
Abstract | Objective: To evaluate the efficacy of sclerotherapy for congenital vascular malformation (CVM) using a combination of polidocanol foam and bleomycin liquid. Methods: A retrospective review of a prospectively collected data on patients who had sclerotherapy for CVM from May 2015 to July 2022 was performed. Results: A total of 210 patients with a mean age of 24.8 ± 2.0 years were included. Venous malformation (VM) was the most common type of CVM, accounting for 81.9% (172/210) of all patients. At 6 months follow-up, the overall clinical effective rate was 93.3% (196/210), and 50% (105/210) of patients were clinically cured. The clinical effective rates in VM, lymphatic, and arteriovenous malformation group were 94.2%, 100%, and 100%. Conclusion: Sclerotherapy using a combination of polidocanol foam and bleomycin liquid is an effective and safe treatment for venous and lymphatic malformations. It is a promising treatment option with satisfactory clinical outcome in arteriovenous malformations. |
Persistent Identifier | http://hdl.handle.net/10722/345338 |
ISSN | 2023 Impact Factor: 1.6 2023 SCImago Journal Rankings: 0.501 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yang, Wei Hong | - |
dc.contributor.author | Xiang, Xian Jun | - |
dc.contributor.author | Li, Hai Lei | - |
dc.date.accessioned | 2024-08-15T09:26:43Z | - |
dc.date.available | 2024-08-15T09:26:43Z | - |
dc.date.issued | 2023 | - |
dc.identifier.citation | Phlebology, 2023, v. 38, n. 7, p. 451-457 | - |
dc.identifier.issn | 0268-3555 | - |
dc.identifier.uri | http://hdl.handle.net/10722/345338 | - |
dc.description.abstract | Objective: To evaluate the efficacy of sclerotherapy for congenital vascular malformation (CVM) using a combination of polidocanol foam and bleomycin liquid. Methods: A retrospective review of a prospectively collected data on patients who had sclerotherapy for CVM from May 2015 to July 2022 was performed. Results: A total of 210 patients with a mean age of 24.8 ± 2.0 years were included. Venous malformation (VM) was the most common type of CVM, accounting for 81.9% (172/210) of all patients. At 6 months follow-up, the overall clinical effective rate was 93.3% (196/210), and 50% (105/210) of patients were clinically cured. The clinical effective rates in VM, lymphatic, and arteriovenous malformation group were 94.2%, 100%, and 100%. Conclusion: Sclerotherapy using a combination of polidocanol foam and bleomycin liquid is an effective and safe treatment for venous and lymphatic malformations. It is a promising treatment option with satisfactory clinical outcome in arteriovenous malformations. | - |
dc.language | eng | - |
dc.relation.ispartof | Phlebology | - |
dc.subject | bleomycin | - |
dc.subject | Congenital vascular malformation | - |
dc.subject | polidocanol | - |
dc.subject | sclerotherapy | - |
dc.subject | venous malformation | - |
dc.title | Sclerotherapy for congenital vascular malformations with mixing foam of polidocanol and liquid of bleomycin | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1177/02683555231184772 | - |
dc.identifier.pmid | 37318342 | - |
dc.identifier.scopus | eid_2-s2.0-85162712804 | - |
dc.identifier.volume | 38 | - |
dc.identifier.issue | 7 | - |
dc.identifier.spage | 451 | - |
dc.identifier.epage | 457 | - |
dc.identifier.eissn | 1758-1125 | - |